Liquidia (LQDA) EBIT Margin (2020 - 2026)

Liquidia (LQDA) recorded quarterly EBIT Margin of 46.29% in Q1 2026, up 115.28% quarter-over-quarter from 21.5% in Q4 2025, and up 118171.0% on a YoY basis from N/an in Q1 2025.

Liquidia (LQDA) EBIT Margin (2020 - 2026) Analysis & Trends

Liquidia's EBIT Margin history runs 7 years deep, the most recent figure standing at 46.29% for Q1 2026.

  • In Q1 2026, EBIT Margin rose 118171.0% year-over-year to 46.29%; the TTM figure through Mar 2026 stood at 15.81% (up 92021.0% YoY), while the FY2025 annual figure was 32.45%, up 83418.0% from the prior year.
  • EBIT Margin was 46.29% for Q1 2026 at Liquidia, up from 21.5% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 46.29% in Q1 2026 to a low of 1237.81% in Q4 2024.
  • Historically, EBIT Margin has averaged 459.38% across 5 years, with a median of 414.43% in 2022.
  • The sharpest annual moves came in 2024 and 2025: EBIT Margin slumped 76360 bps in 2024, then surged 125932 bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 121.21% in 2022, then sank by 381 bps to 583.45% in 2023, then tumbled by 112 bps to 1237.81% in 2024, then soared by 102 bps to 21.5% in 2025, then soared by 115 bps to 46.29% in 2026.
  • The last three EBIT Margin figures came in at 46.29% (Q1 2026), 21.5% (Q4 2025), and 3.25% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 16.37%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 36.83%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 20.77%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 23.74%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 22.39%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -122.23%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 21.55%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -12.88%
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 46.29%

Historic Data

Download Data
DateValue
Mar 31, 2026 46.29%
Dec 31, 2025 21.50%
Sep 30, 2025 3.25%
Jun 30, 2025 -424.41%
Mar 31, 2025 -1,135.42%
Dec 31, 2024 -1,237.81%
Sep 30, 2024 -656.23%
Jun 30, 2024 -743.29%
Mar 31, 2024 -969.08%
Dec 31, 2023 -583.45%
Sep 30, 2023 -404.87%
Jun 30, 2023 -476.91%
Mar 31, 2023 -205.48%
Dec 31, 2022 -121.21%
Sep 30, 2022 -279.02%
Jun 30, 2022 -228.94%
Mar 31, 2022 -414.43%
Dec 31, 2021 -353.41%
Sep 30, 2021 -222.71%
Jun 30, 2021 -188.21%